Medytox Inc., 10% Owner at Evolus, Inc. (EOLS), bought 103,000 shares at $10.56 ($1.1M) on 2021-08-20, disclosed to the SEC on 2021-08-23.
Open-market purchase of $1.1M EOLS by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.51 | 55,000 | $578K | 53.3% |
| 2 | $10.56 | 48,000 | $507K | 46.7% |
| Total | $10.53 avg | 103,000 | $1.1M | 100% |
| Filing → |
| EOLS | BUY | 2023-02-06 | $565K | — | Filing → |
| EOLS | SELL | 2023-02-06 | $818K | — | Filing → |
| EOLS | SELL | 2022-10-07 | $689K | — | Filing → |